Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Amortization of Deferred Charges (2021 - 2025)

P3 Health Partners (PIII) has disclosed Amortization of Deferred Charges for 4 consecutive years, with $11.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortization of Deferred Charges rose 10458.65% year-over-year to $11.0 million, compared with a TTM value of $11.5 million through Sep 2025, up 3823.63%, and an annual FY2024 reading of $87000.0, down 81.57% over the prior year.
  • Amortization of Deferred Charges was $11.0 million for Q3 2025 at P3 Health Partners, up from $71000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $11.0 million in Q3 2025 and bottomed at -$140000.0 in Q1 2024.
  • Average Amortization of Deferred Charges over 4 years is $1.1 million, with a median of $174197.5 recorded in 2021.
  • The sharpest move saw Amortization of Deferred Charges crashed 150.18% in 2024, then soared 10458.65% in 2025.
  • Year by year, Amortization of Deferred Charges stood at $1.3 million in 2021, then crashed by 78.07% to $279000.0 in 2023, then tumbled by 73.48% to $74000.0 in 2024, then soared by 14739.19% to $11.0 million in 2025.
  • Business Quant data shows Amortization of Deferred Charges for PIII at $11.0 million in Q3 2025, $71000.0 in Q2 2025, and $331000.0 in Q1 2025.